This article is in the news archive.
Professor Barbara Sahakian elected President of the International Neuroethics Society
The Governing Board of the International Neuroethics Society announced today that Professor Barbara Sahakian of Cambridge University will be the next President of the Society. She will take office in February 2014 and will serve a two year term. She follows Dr. Steven Hyman who was the founding President of the INS and has served since 2006.
Professor Sahakian is Professor of Clinical Neuropsychology at the Department of Psychiatry, and Medical Research Council / Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge School of Clinical Medicine, and Honourary Consultant Clinical Psychologist, Cambridge University Hospitals NHS Foundation Trust. After completing a Ph.D. in Experimental Psychology at The University of Cambridge, she studied for a Diploma in Clinical Psychology, became a Chartered Psychologist, and was a founding member of The International Neuroethics Society.
She has an international reputation in the fields of cognitive psychopharmacology, neuroethics, neuropsychology, neuropsychiatry and neuroimaging. She has been involved in neuroscience and mental health policy, including the Foresight Project on Mental Capital and Wellbeing, the Medical Research Council Strategic Review Report on Mental Health and the Grand Challenges in Global Mental Health.
Professor Sahakian is co-inventor of the CANTAB computerized neuropsychological tests, which are in use world-wide. She is well known for her research work on cognition, depression, and cognitive enhancement, and other issues of importance to neuroethics. She has more than 300 publications in leading scientific journals. Her current program of research, funded by the Wellcome Trust and Medical Research Council, investigates the neurochemical modulation of impulsive and compulsive behavior in neuropsychiatric disorders, such as unipolar and bipolar depression and attention deficit hyperactivity disorder. She currently serves as president of the British Association for Psychopharmacology. Her latest book (2013), with Jamie Nicole LaBuzetta, is Bad Moves: How decision making goes wrong, and the ethics of smart drugs.
In late 2014, the INS Governing Board will select a President-Elect who will begin to serve in that role in February 2015, becoming President in February 2016. The Nominating Committee, which is selected in part by the membership and in part by the Governing Board, is charged with selecting the slate of nominees to be presented to the INS Governing Board.
Posted on 12/08/2013
Go to the news index page.